Holly Martinez Associate

Holly Martinez was interviewed by the Portland Business Journal for a Q&A feature article covering why psilocybin should not be a Schedule 1 drug. Holly, a litigation lawyer, is a member of a firm legal team representing a Seattle doctor in a case that is seeking to get the Drug Enforcement Administration to reclassify psilocybin as a Schedule 2 drug.

James Williams, Thomas Tobin, Andrew Kline, Holly Martinez and Caleb Bacos were mentioned in “DEA Wrongly Refuses To Reconsider Psilocybin, 9th Circ. Told,” an article Law360, regarding the case of a Washington state clinic fighting for terminally ill patients' right to use psilocybin.

Perkins Coie lawyers were mentioned in “DEA Erred In Rejecting Psilocybin Therapy, 9th Circ. Hears,” an article Law360, regarding a doctor who is urging the U.S. Court of Appeals for the Ninth Circuit to find that the U.S. Drug Enforcement Administration (DEA) erred when it stated that psilocybin, the psychedelic compound produced by certain mushrooms, has no medical value.